欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-PI3K/Akt/mTOR Pathway-PI3K-cyclo-CRVLIR
cyclo-CRVLIR

Chemical Structure : cyclo-CRVLIR

CAS No.:

cyclo-CRVLIR

货号: PC-20008Not For Human Use, Lab Use Only.

cyclo-CRVLIR is a cyclic peptide that binds selectively to p110α RAS binding domain (p110α-RBD) with ITC Kd of 3 uM, blocks p110α/RAS interaction in vitro and KRAS cancer cell lines.

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

    生物&药学活性

    cyclo-CRVLIR is a cyclic peptide that binds selectively to p110α RAS binding domain (p110α-RBD) with ITC Kd of 3 uM, blocks p110α/RAS interaction in vitro and KRAS cancer cell lines.
    cyclo-CRVLIR is specific for the RBD of p110α and not the other PI3K isoforms, and shows no affinity to KRAS or the structurally-related RAF-RBD.
    cyclo-CRVLIR blocks p110α/KRAS interaction using MST assays with Kd of 4.4 uM.
    Cyclo-CRVLIR (2, 10 and 50 µM) inhibits AKT phosphorylation (pAKT-Ser473) in human lung cancer cell line H1792.

    物理化学性质&存储条件

    分子量 728.96
    分子式 C31H60N12O6S
    外观性状 Solid
    CAS No.
    储存条件
    固体粉末
    -20°C 12 个月; 4°C 6 个月
    配置液
    -80°C 6 个月; -20°C 6 个月
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    1,1'-(((3S,6R,9R,12R,15R,18S)-15-((R)-sec-butyl)-12-isobutyl-9-isopropyl-3-(mercaptomethyl)-4,7,10,13,16-pentaoxo-1-oxa-2,5,8,11,14,17-hexaazacyclooctadecane-6,18-diyl)bis(propane-3,1-diyl))diguanidine

    参考文献

    1. Ismail M, et al. Sci Rep. 2023 Feb 2;13(1):1889.

    备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    联系我们 sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    询单

    • *产品名称:
    • *姓名:
    • *邮箱:
    • *公司名称:
    • *询单数量:
    • *国籍:
    • 询单信息: